Table 1 |
||||||
|
Summary of Demographic Data and Disease Characteristics at Baseline (all randomized subjects) |
||||||
|
Desloratadine |
||||||
|
Characteristic |
2.5 mg (n = 173) |
5 mg (n = 172) |
7.5 mg (n = 173) |
10 mg (n = 172) |
20 mg (n = 172) |
Placebo (n = 174) |
|
|
||||||
|
Mean (range) age, years |
34 (13–73) |
34 (12–75) |
34 (12–73) |
34 (12–70) |
34 (12–72) |
35 (12–63) |
|
Age group, years |
||||||
|
12–17 |
22 |
26 |
25 |
28 |
25 |
22 |
|
18–65 |
150 |
143 |
145 |
143 |
145 |
152 |
|
>65 |
1 |
3 |
3 |
1 |
2 |
0 |
|
Sex |
||||||
|
Male |
73 |
68 |
68 |
71 |
62 |
81 |
|
Female |
100 |
104 |
105 |
101 |
110 |
93 |
|
Mean duration (range) of seasonal allergic rhinitis, years |
18 (2–60) |
18 (2–55) |
16 (2–50) |
17 (2–49) |
16 (2–48) |
17 (2–50) |
|
|
||||||
|
Salmun and Lorber BMC Family Practice 2002 3:14 doi:10.1186/1471-2296-3-14 |
||||||
